Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes?
(MedPage Today) -- Insulins, SGLT2 inhibitors, and GLP-1 receptor agonists can likely be manufactured for prices "far below" their current prices, according to an economic evaluation of manufacturing costs in JAMA Network Open.
In related news...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Diabetes | Endocrinology | Herpes | Hormones | Men | Menopause | Neurology | SGLT2 Inhibitors